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3Department of Physics, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USASemiconductor quantum dots and metal nanoclusters are fluorescent nanoparticles with diameters in
the few-nanometer range. In recent years, they have captured a great deal of attention as experimental
tools in the life sciences for diverse applications including imaging, bioassays and therapy. It is crucially
important to understand how these small nanoparticles behave in complex biological environments,
especially in view of their potential for biomedical applications. In this review, we shall highlight recent
advances in exploring the behavior of fluorescent nanoparticles at the nano–bio interface, including
their interactions with proteins and cells, their intracellular stability as well as their in vivo behavior.Introduction
Fluorescence-based spectroscopy and imaging techniques have
long been valued as reliable and quantitative tools in the bios-
ciences, owing to the availability of a wide array of fluorogenic
probes and straightforward bioconjugation techniques, as well as
their high sensitivity and multiplexed detection capabilities [1–3].
It is important to realize that the photophysical and photoche-
mical properties of the fluorescence markers are often key and
limiting factors in these measurements. Thus, researchers keep on
pursuing novel fluorescence probes with improved properties.
With the rapid advancement of nanotechnology in recent years,
a wide range of intrinsically fluorescent nanomaterials have
become available as probes, including semiconductor quantum
dots (QDs), metal nanoclusters (NCs), dye-doped silica or polymer
nanoparticles (NPs), up-converting NPs and nanodiamonds [4].
Fluorescent nanomaterials frequently exhibit excellent photo-
physical properties, color tunability and facile synthesis. With an
extremely high surface-to-volume ratio compared with their bulk
materials, NPs can act as multivalent scaffolds for further supra-
molecular assemblies as well as controllable bioconjugation [5,6].
These properties make NP-based fluorophores promising as probes
for fluorescence-related applications. Indeed, important biological
and biomedical applications of NPs have been reported, such as in*Corresponding author: Nienhaus, G.U. (uli.nienhaus@kit.edu)
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namic therapy [7–10].
It is crucially important to understand how fluorescent NPs
behave in the complex biological environment. This is obvious
when we think of biomedical applications, but we should not
overlook that the widespread use of nanotechnology will inevi-
tably lead to an unintended exposure of living systems including
humans. Understandably, great concerns have recently been
voiced regarding the safe use of nanotechnology [11,12], which
calls for a deep understanding of the processes occurring at the
interface between nanomaterials and biological systems, a.k.a. the
nano–bio interface. The nano–bio interface comprises a dynamic
series of interactions between nanomaterials surfaces and biomo-
lecular surfaces, which are governed by a variety of forces includ-
ing long-range forces arising from attractive van der Waals and
repulsive electrostatic double-layer interactions, and short-range
forces arising from charge, steric, depletion and solvent interac-
tions. These interactions determine such processes as the forma-
tion of protein corona, cellular contact, endocytosis and
intracellular transport [13].
Interactions of NPs with biological systems, including proteins,
cells and living organelles, may alter the NP surface properties and
thus their subsequent biological responses. Moreover, considering
the large surface-to-volume ratio of fluorescent NPs, surface changes
are likely to change their photophysical properties, which may in
turn affect their fluorescence properties. Clearly, understanding thehttp://dx.doi.org/10.1016/j.mattod.2013.03.005ccess under CC BY-NC-ND license. 














processes at the nano–bio interface of fluorescent NPs is of essential
importance for their use in biological applications.
In this review, we intend to highlight several recent advances in
exploring the behavior of fluorescent NPs at the nano–bio inter-
face. Among the wide variety of fluorescent NPs, we focus here on
semiconductor QDs and metal NCs. While semiconductor QDs
have already become very popular as fluorescent NPs owing to
their commercial availability and excellent photophysical proper-
ties [14,15], metal NCs, composed of a few to a hundred atoms, are
a novel type of fluorescent NPs that recently have attracted enor-
mous interest because of their ultrasmall size and facile synthesis
[16,17].
Interactions of fluorescent nanoparticles with proteins
NPs possess a huge active surface in comparison to their bulk
counterparts through which they can interact with biomatter in
their environment. Once exposed to biological fluids, NP surfaces
will be rapidly covered with dissolved components, in particular
proteins, forming the so-called ‘‘protein corona’’ around NPs
[18,19]. Consequently, the initial interactions of NPs with biolo-
gical entities, such as cells, tissues and organs, will be mediated by
the protein layer adsorbed on the NP surface. Based on a thorough
understanding of these interactions, one can potentially predict
and even control the behavior of NPs at the nano–bio interface,
which will greatly assist in their safe use in biomedical applications
[20].
Many experimental techniques have been employed to study
NP–protein interactions, including various spectroscopy methods,
size-exclusion chromatography, isothermal titration calorimetry,
X-ray crystallography, surface plasmon resonance and mass spce-
troscopy [21]. Intrinsically fluorescent NPs have the key advantage
that their interactions with proteins can be directly investigated by
fluorescence-based techniques such as fluorescence correlation
[(Figure_1)TD$FIG]FIGURE 1
(a) Schematic illustration of protein adsorption-enhanced AuNC fluorescence. (b)
concentration (from left to right), under a UV light source with 365 nm emission.
lysozyme and (f ) apolipoprotein E4 concentration. The blue lines represent fits to
with permission from John Wiley and Sons.spectroscopy (FCS) [22,23]. Based on the analysis of the duration
of brief bursts of photons from individual diffusing emitters during
their brief sojourn in the observation volume of a confocal micro-
scope, FCS can provide quantitative information on NP–protein
interactions, specifically the increasing NP size due to protein
adsorption, protein binding affinity and even the protein orienta-
tion on the NP surfaces [24–26]. For instance, our group has
studied the adsorption of human serum albumin (HSA) onto small
carboxylic acid-functionalized CdSe/ZnS QDs with an overall dia-
meter of 16 nm by using FCS [27]. The thickness of the HSA corona
around QDs, 3.3 nm, corresponded to a monolayer of proteins
adsorbed in a specific orientation. The dissociation coefficient was
in the micromolar concentration range, and an anti-cooperative
binding isotherm was observed.
Protein binding to fluorescent NPs can also be monitored by
simple steady-state or time-resolved fluorescence spectroscopy.
Poderys and coworkers investigated interactions of thioglycolic
acid-coated CdTe QDs with proteins by measuring the photolu-
minescence intensity of QDs upon titration with bovine serum
albumin (BSA) [28]. A gradual increase in QD photoluminescence
(up to 120% of the initial intensity) clearly suggested the adsorp-
tion of proteins on the QDs. The enhanced emission efficiency of
QDs may result from the recovery of surface defects by the formed
protein corona [29]. Recently, we investigated interactions of
proteins with ultrasmall gold nanoclusters (AuNCs, diameter
3.2 nm) coated with dihydrolipoic acid (DHLA, Fig. 1) [30]. Based
on the substantial increase in the fluorescence intensity of AuNCs
upon protein adsorption, the apparent binding affinities of four
different proteins (HSA, apotransferrin, lysozyme and apolipopro-
tein E4) to AuNCs were measured, yielding values in the micro-
molar range. Time-resolved fluorescence studies further revealed
significantly enhanced long lifetime components of the AuNC
luminescence decay curves upon protein association. SimilarPhotographs of AuNC solutions in the presence of increasing protein
Fluorescence intensity of AuNCs as a function of (c) HSA, (d) transferrin, (e)
the data points using the adapted Hill equation. Reproduced from Ref. [30]
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eviewchanges in the emission decays upon protein adsorption have
recently also been reported for other fluorescent NPs, such as
AgNCs [31], AuAg alloy NCs [32], and nanodiamonds [33]. These
results clearly show that the photophysical properties of NPs are
sensitive to protein binding, and especially for their use as fluor-
escence markers, these results call for a thorough investigation of
photophysical effects in the biological environment.
An important aspect is that proteins may change their confor-
mation upon adsorption onto NP surfaces because they are weakly
stabilized biomacromolecules that can fluctuate among a huge
number of conformational substates [34,35]. Protein adsorption
onto NPs may constitute a significant energetic perturbation that
induces conformational changes and, concomitantly, alters its
function [36–38]. Indeed, conformational changes of HSA on
the surface of mercaptoacetic acid-capped CdSe/ZnS QDs
(3.4 nm diameter) have been reported [39]. Based on their Fourier
transform infrared (FTIR) and circular dichroism (CD) spectro-
scopy data, the authors suggested that HSA underwent substantial
conformational changes at both secondary and tertiary structure
levels upon interaction with QDs. In another study, Shen et al. [40]
reported that hemoglobin adsorbed onto the surface of cationic
CdS QDs (9.1 nm diameter) exhibited a loose conformation in
which the a-helix content was substantially decreased. The struc-
tural alterations resulted in an orientational change of the heme
vinyl groups, which was revealed by Raman spectroscopy.
Actually, ideal optical probes are expected to interfere only
minimally – if at all – with the function of the conjugated bio-
molecules as well as the investigated biological processes. Espe-
cially fluorescent NPs with small size are favorable for biological
applications [41]. Researchers have recently addressed the critical
size issue by either making the NP surface coating thinner [42,43]
or by producing fluorescent NPs with ultrasmall cores (e.g., few
atom-composed metal NCs) [16]. In a recent paper, we reported
that both tryptophan emission and CD spectra of HSA remained
essentially unchanged upon binding to AgNCs with an overall
diameter of 2.1 nm, suggesting that major perturbations of the
protein conformation upon adsorption onto AgNC surfaces are
[(Figure_2)TD$FIG]FIGURE 2
(a) Schematic depiction of blocked transferrin–transferrin receptor (Tf–TfR) intera
representation of the loss of targeting capability of Tf-conjugated NPs toward TfR
where present, could also compete for TfR). Reproduced from Ref. [45] with perm
60absent [31]. In another study, Chou and coworkers observed that
insulin retained its bioactivity in the protein–AuNC conjugates,
evaluated by examining the regulation of the blood glucose level
in mice by insulin-AuNCs [44]. These results suggest the distinct
advantage of ultrasmall fluorescent NPs as promising optical labels
for biological applications. However, it is very clear that further
structural studies are required to advance our understanding of the
protein corona.
For applications of fluorescent NPs in targeted drug delivery,
protein–NP interactions need to be particularly taken into
account, as protein adsorption can adversely affect the biological
interactions with these NPs. In a recent study, Dawson and cow-
orkers have shown that the formation of a biomolecular corona
around the surface of NPs can alter their targeting capabilities [45].
Using transferrin-conjugated fluorescent silica NPs, they found
that proteins in the media can shield transferrin from binding to
its cognate receptor on cells and in solution (Fig. 2). Although NPs
continue to enter cells, the targeting specificity of transferrin was
lost, suggesting that the formation of a protein corona can ‘screen’
the targeting molecules on the surface of NPs and cause a loss of
specificity in targeting. One important implication of these results
is that the design of new NPs for application in biological media
requires a profound understanding of the interactions between
NPs and biomolecules.
Interactions of fluorescent nanoparticles with cells
Interactions of nanomaterials with cells are critical for many
applications such as cellular imaging, diagnosis and therapy
because applications often require NPs to enter cells [46–48].
Rising concerns over the biological safety of NPs also call for a
better understanding of how NPs behave upon entering cells [49].
To this end, it is necessary to advance our knowledge of how
fluorescent NPs interact with cells, including uptake and transport
pathways, intracellular fate, effects on cellular function and so on.
While NPs can be delivered into cells by physical approaches
such as direct microinjection and electroporation, most NPs are
capable of entering cells via endocytosis, a fundamental processction in solution in the presence of serum proteins. (b) Schematic
on the cell surface in the presence of serum proteins (endogenous Tf,
ission from Nature Publishing Group.














that is used by essentially all cells to internalize (bio)molecules
[50]. Indeed, many fluorescent NPs have been engineered to enter
cells through endocytosis and deliver their cargo within the cell.
Endocytosis encompasses several active cellular mechanisms,
which are generally divided into two categories: phagocytosis
and pinocytosis. Phagocytosis is efficiently carried out by specia-
lized cells, professional phagocytes, which take up larger particles;
pinocytosis of smaller NPs (a few to about a hundred nanometers)
occurs in almost all eukaryotic cells [51]. Unraveling endocytosis
mechanisms during NP internalization is crucial to understand the
fate of NPs and the effect on the biological activity of the cargo
transported inside the cells.
Fluorescent NPs allow one to directly visualize the uptake process
and track NPs within live cells in real time using fluorescence
microscopy [52]. Uptake and intracellular transport of D-pencilla-
mine-coated QDs [53] (DPA-QDs) of 8 nm diameter by live HeLa
cells have been investigated systematically by using spinning disk
and 4Pi confocal microscopy [54]. Interestingly, these small QDs
were observed to accumulate at the plasma membrane prior to
internalization (Fig. 3). The same behavior has also recently been
observed for the cellular uptake of AuNCs with an overall diameter
of 3.3 nm [55]. Indeed, both theoretical [56] and experimental [57]
studies have indicated that there exists a critical NP density/size to
trigger cellular uptake, which can be achieved through clustering of
smallNPs so that the entire aggregate is internalizedasa whole. Such
a behavior is in stark contrast with the internalization of larger NPs,
e.g., polystyrene NPs with 100 nm diameter, where no accumula-
tion at the plasma membrane was observed [58,59].
By using inhibitors that interfere with particular uptake path-
ways, uptake mechanisms of NPs can be elucidated. For instance,
our recent studies revealed that clathrin-mediated endocytosis
plays a significant role in the uptake of both DPA-QDs [54] and
dihydrolipoic acid-coated AuNCs [55], which were actively trans-
ported along microtubules toward the perinuclear region. Co-
labeling different cell organelles such as early endosome, lysosome
and nucleus further showed intracellular trafficking of the AuNCs
through the endosomal pathway. These NPs were ultimately
transferred to lysosomes, but did not enter the nucleus even after
24 h. The cellular uptake kinetics and mechanisms of fluorescent
[(Figure_3)TD$FIG]FIGURE 3
(a) Time sequence of merged two-color confocal images of a HeLa cell exposed
with CellMask Deep Red (red). Scale bar: 10 mm. (b) Schematic diagram illustratin
intracellular fate. Reproduced from Ref. [54] with permission from the American Cnanodiamonds have also been evaluated through fluorescence
imaging by either taking advantage of their intrinsic emission
[60] or conjugation with additional fluorophores [61]. Similarly,
these nanodiamonds of size less than 50 nm enter cells mainly by
endocytosis through a clathrin-mediated process, and localization
studies revealed that they reside in early endosomes and lysosomes
with eventual release back into the cytoplasm.
Interactions of NPs with cells depend on many parameters,
including the physicochemical properties of NPs, NP surface mod-
ifications, cell types as well as the cell cycle [62–65]. Indeed,
Monteiro-Riviere and coworkers [66] recently showed that the
uptake mechanism of carboxylic acid-terminated CdSe/ZnS QDs
is different for dendritic cells and HEK cells [67], and that uptake
also depends on the state of differentiation of the dendritic cells. In
another study, interactions of CdSe QDs of various sizes and
shapes with live immune cells were studied by high-speed total
internal reflectance fluorescence (TIRF) microscopy [68]. This work
showed that both size and aspect ratio of QDs are critical char-
acteristics, which significantly affect their interactions with the
plasma membrane, cellular uptake efficiency as well as localization
within intracellular vesicles. Also, QDs with the same size but
varied short ligand surface functionalization were observed to
enter human kidney and liver cells through lipid raft-mediated
endocytosis, although to significantly different extents [69]. Poly-
ethylene glycol (PEG) has been used frequently for coating QD
surfaces to improve their biocompatibility and to prolong their
blood circulation time by reducing nonspecific protein adsorp-
tion; however, cellular uptake of PEG-coated QDs was shown to be
severely reduced [70,71].
To better understand the mechanisms of NP–cell interactions,
several studies have examined the interactions of fluorescent NPs
with cellular membranes [72,73] or synthetic lipid bilayers [74].
Jiang and coworkers have investigated the passive transport of
DPA-QDs across the plasma membranes of red blood cells, which
are incapable of endocytosis [72]. Fluorescence microscopy studies
revealed that zwitterionic QDs penetrated cell membranes and
entered the cells. Meanwhile, entrance of DPA-QDs did not cause
any measurable leakage of calcein violet AM, a cell-membrane-
permeable dye that becomes impermeable after hydrolysis byto DPA-QDs (green) for different times. The plasma membrane was stained
g the key steps involved in DPA-QD uptake, active transport and
hemical Society.
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[(Figure_4)TD$FIG]
FIGURE 4
Fluorescence microscopy experiment to examine if DPA-QD uptake by red blood cells (RBCs) causes holes in the plasma membrane. RBCs were incubated
with (a) calcein violet AM, and subsequently (b) with 10 nM QDs for 6 h. Scale bar: 5 mm. (c) Schematic diagram illustrating the interaction of QDs with
planar membranes, formed by hydrophobic interactions between vesicles and 1-dodecanethiol monolayers self-assembled on a gold electrode. Reproduced











eviewintracellular esterase (Fig. 4). Moreover, surface-enhanced infrared
absorption spectroscopy and electrochemistry studies revealed a
markedly enhanced flexibility of the lipid bilayers in the presence
of NPs and the overall membrane structure remained intact with-
out persistent holes formation in the bilayers. Previously, NPs with
very small dimensions and positive charge have been observed to
pass through cell membranes by forming membrane holes, gen-
erating noticeable cytotoxic effects in the process [75,76]. There-
fore, it appears feasible that carefully designed materials with
optimally engineered surface properties may pass through mem-
branes without disrupting the membrane.
Intracellular stability of fluorescent nanoparticles
Stability of NPs in live cells is an important issue that recently
captured the attention of many researchers. Endocytosed NPs are
passed from endosomes to lysosomes, and lysosomes have a low
pH and contain proteases and other enzymes that degrade
a variety of biological substances [77]. Consequently, surface62coatings and even core materials of NPs face the risk of degradation
in this corrosive intracellular milieu, which may not only com-
promise NP function but also give rise to NP toxicity. Knowledge
about the intracellular stability of fluorescent NPs is important for
effective utilization of these optical materials in many biological
applications, and can also assist in the design of stable and
biocompatible NPs [78].
The intracellular stability of fluorescent NPs has been rarely
explored due to the lack of adequate experimental tools. Rotello
and coworkers recently proposed a label-free method to quantify
the stability of four types of cationic CdSe/ZnS QDs in live cells by a
combined use of laser desorption ionization mass spectroscopy
(LDI-MS) and inductively coupled plasma mass spectrometry (ICP-
MS) [79]. The total molar amount of QDs taken up by cells was first
quantified using ICP-MS, whereas the amount of QD surface
ligands was measured by LDI-MS (Fig. 5). The difference between
the amount of QDs determined by ICP-MS and the amount of
surface coatings determined by LDI-MS gives the amount of
Materials Today  Volume 16, Number 3 March 2013 RESEARCH
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FIGURE 5
Parallel measurement of total QD uptake and monolayer amounts inside cells using ICP-MS and LDI-MS, respectively. The difference between the values















ligands released from the QDs, providing a quantitation of the
stability of the coating inside the cells. With this approach, they
demonstrated that QD stability is correlated with both NP size and
monolayer structure: relatively small QDs with bidentate ligands
such as dithiolate possess a better stability in live cell imaging
applications. Indeed, previous studies by the Mattoussi lab and
others have suggested an enhanced colloidal stability of QDs in
biological media upon surface coating with bidentate-based
ligands such as PEG-modified ones [80] or sulfobetaine-appended
DHLA [81].
In another study, the intracellular aggregation kinetics of QDs
with three different surface chemistries were evaluated by fluor-
escence microscopy observation, revealing that the QD intracel-
lular aggregation behavior is strongly dependent on the surface
chemistry [82]. QDs coated with bidentate zwitterionic ligands
exhibited better stability, and diffused within the entire cell cyto-
sol for at least 24 h. In contrast, QDs stabilized with other surface
chemistries, i.e., encapsulation into phospholipid micelles or
amphiphilic copolymers showed rapid aggregation in the cyto-
plasm. In line with these results, Chen et al. [83] recently exam-
ined the intracellular fate of polymer coatings on QDs by labeling
the coatings with fluorophores. The emission of the dyes conju-
gated to the QD coatings remained quenched upon internalization
during 4 h incubation of the cells. Fluorescence from these dyes
appeared after 8 h, however, suggesting that the polymer coating
dissociated from the QD surfaces in the lysosomes of the cells.
These results contribute to advancing our knowledge of the fate of
fluorescent NPs in biological environments. Considering the ver-
satile coating strategies and surface chemistries of fluorescent NPs,
more research will be necessary to evaluate their stability in
biological systems.
In vivo behavior of fluorescent nanoparticles
Recent advances on fluorescent NPs for in vivo biomedical applica-
tions have prompted a close scrutiny of their behavior in vivo,
including biodistribution, clearance, metabolism, and toxicity
[84–87]. A comprehensive knowledge of the in vivo toxicity of
these nanoscale materials is of essential importance for their
safe biomedical application. While toxicology data currently arefrequently derived from in vitro studies of cultured cells, these
approaches may not capture natural in vivo responses. For exam-
ple, several reports have demonstrated QD toxicity in cell culture
studies [88,89], yet this toxicity has not been observed in vivo in
small animals [90–92]. Evidently, the in vivo behavior of NPs,
which is closely related to their surface chemistries, sizes, doses,
and administration routes, is a rather complicated issue.
In an early study, Chan and coworkers provided the first
quantitative glimpse of in vivo kinetics, clearance, and metabo-
lism of semiconductor QDs following their intravenous admin-
istration to Sprague–Dawley rats [93]. QDs coated with
mercaptoundecanoic acid cross-linked with lysine were observed
to exhibit a lower clearance from plasma than QDs conjugated
with BSA. In addition, the biodistribution of these QDs was
different. The role of surface coatings on the in vivo behavior of
QDs has also been examined by oral administration in Drosophila
melanogaster [94]. The results indicated that cadmium-based QDs
elicited a significant lifespan decrease, high levels of oxidative
stress and genotoxicity, mainly due to the in vivo release of Cd2+
ions. The surface engineering of QDs may affect the uptake and
bioaccumulation in the organism, thereby decreasing the overall
toxicity but not entirely eliminating it. While PEG is typically
considered an inert molecule, the length of the PEG chain appears
to have a marked effect on the biodistribution and clearance of
capped NPs, e.g., PEGylated InAs(ZnS) QDs [95]. NPs with ultra-
short (i.e., dimeric) PEG chains retain a hydrophobic character
and result in rapid uptake by the liver; relatively long PEG chains
(i.e., 22-mers) are highly hydrophilic, so the NPS remain in the
vasculature for long periods of time. NPs coated with PEGs of
intermediate chain lengths exhibit specific tissue and organ dis-
tribution and clearance.
Using intravenously administered QDs in rodents as a model
system, Frangioni and coworkers [96] recently reported that the in
vivo behavior of QDs was greatly dependent on their hydrody-
namic size. They suggested that QDs smaller than 5.5 nm can be
rapidly and efficiently metabolized by renal clearance, while QDs
larger than 15 nm escape renal excretion and accumulate in the
liver and spleen. Following this study, the same group later inves-
tigated the translocation behavior of QDs from the lung airspaces63











eviewto the body [97]. NPs small than 34 nm with a noncationic surface
were observed to translocate rapidly from the lung to mediastinal
lymph nodes, while NPs smaller than 6 nm traffic rapidly from the
lung to the lymph nodes and further on to the blood stream.
Finally, they are cleared by the kidneys.
For in vivo biomedical applications, renal clearance is of funda-
mental importance to ensure that the contrast agents can be
effectively and quickly cleared from the body, thereby avoiding
in vivo toxicity due to long-term effects. Compared with other NPs,
the much smaller metal NCs appear advantageous in regard to
highly efficient clearing. Indeed, recent studies revealed that over
50% of 2 nm glutathione (GSH)-coated luminescent AuNPs were
found in the urine of mice within 24 h after intravenous injection,
and up to 65% after 72 h (Fig. 6) [98]. Only 3.7% of these lumi-
nescent AuNPs accumulated in the liver of mice. This finding is in
stark contrast to the previously reported biodistribution of larger
AuNPs (50–94% presence in the liver) [99,100]. The efficient renal
clearance of the 2-nm AuNPs resulted not only from their small
size but also from their coating with GSH, which stabilizes the[(Figure_6)TD$FIG]
FIGURE 6
Renal clearance and biodistribution studies of GSH-AuNPs in mice. (a) Luminesce
injection (p.i.) (red), and spectrum (green) after subtracting the urine background
AuNPs in urine 2 and 24 h p.i. and control urine upon excitation with ultraviolet
filter. (b) Gold concentrations in the urine at 2, 6, 24, 48, 72, and 120 h p.i. measu
intravenous injection. Reprinted from Ref. [98] with permission from John Wiley a
64luminescent AuNPs during blood circulation. In another study,
Zhang et al. [101] systematically explored the in vivo renal clear-
ance, biodistribution and toxicity responses of Au25NCs coated
with either GSH or BSA. Their results suggest that the surface of
AuNCs plays a very important role in biodistribution and toxicity.
These studies provide an important foundation for the design and
development of fluorescent NPs for future cancer therapy, drug
delivery, and bioimaging applications.
Perspective
Fluorescent NPs hold great promise as alternatives and even sub-
stitutes to conventional fluorophores for many biomedical appli-
cations. It is important to carefully characterize their behavior in
the complicated biological environment prior to widespread appli-
cation in biomedicine. Although impressive progress has been
made in recent years in exploring the interactions of these nanos-
cale materials with biological systems, we are still far from the deep
understanding of how they behave at the nano–bio interface,
especially regarding their in vivo responses. Many questions remainnce spectra of urine (black), AuNPs (blue), the urine collected 2 h post-
(excitation wavelength 420 nm). (Inset) Luminescence images of GSH-
(UV) light; the emitted light was collected through a 630/75-nm bandpass
red by ICP-MS. (c) Biodistribution of GSH-AuNPs in mice 24 h after
nd Sons.














to be answered, i.e., how does protein adsorption impact the
kinetics and metabolism of NPs in vivo? What is their long-term
fate? How long can their optical properties survive in living
organisms? Addressing these questions will be necessary to fully
elucidate their utilization, transformation, and final fate within
biological systems.
Future development of fluorescent NPs for biomedical applica-
tions will benefit from ongoing advances in the materials sciences,
continually producing novel NPs with improved photophysical
and chemical properties. Particularly, a more precise control over
NP surface chemistry will definitely allow researchers to better
understand how NP properties can affect protein adsorption,
structure, and subsequent biological outcomes [102]. While con-
jugation of NPs with biomolecules is crucial for controlling the
biological activity of the resulting NP bioconjugates, current con-
jugation strategies still suffer from inefficiency, cross-reactivity
and reproducibility. There is an urgent need for the development
of more efficient and simpler bioconjugation strategies, yet this
area is presently underexplored [103]. Another point that has
recently moved center stage is the establishment of reliable, stan-
dardized methods and instruments for the characterization of
physical and chemical properties of NPs, and nanomaterials in
general. Any serious toxicity assessment has to be based on the
precise knowledge of the nanomaterials properties; therefore,
characterization procedures have recently been attracting a great
deal of attention in the broader nano-community [104].
Fluorescent NP-based advanced imaging techniques will offer
unique tools for observing nano–bio interactions with nanoscale
precision and resolution. For instance, the combination of the
excellent photostability of fluorescent nanodiamonds with the
sub-diffraction imaging capability of STED microscopy [105] in
live cell imaging has been reported [106], which will open up many
exciting new opportunities to probe intracellular interactions.
Alternatively, photoswitchable fluorescent NPs [107], which can
alternate their emission between two colors or between bright and
dark states in response to external light stimulation, also have
great potential in developing super-resolution imaging techniques
[108] to visualize interactions in biological systems.
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